EXPERIMENTAL STUDIES
Vascular smooth muscle proliferation
Synergistic interaction between serotonin and low density lipoproteins
Shinji Koba, MD*,
Rajbabu Pakala, PhDa,
Takuya Watanabe, MD*,
Takashi Katagiri, MD* and
Claude R. Benedict, MD, DPhil, FACCa
a Department of Internal Medicine, Division of Cardiology, University of Texas Health Science Center at Houston, Houston, Texas, USA
* Showa University School of Medicine, Tokyo, Japan
Manuscript received September 21, 1998;
revised manuscript received May 18, 1999,
accepted June 28, 1999.
Reprint requests and correspondence: Dr. Claude R. Benedict, Department of Internal Medicine, Division of Cardiology, The University of Texas Health Science Center, 6431 Fannin, MSB 6.039, Houston, Texas 77030
OBJECTIVES
The purpose of this study was to examine whether low density lipoproteins (LDLs) or mildly oxidized LDL (mox-LDL) are mitogens for vascular smooth muscle cells (VSMCs) and whether they can act synergistically with serotonin (5HT), a known mitogen for VSMC, in potentiating the proliferative effect of 5HT on VSMC.
BACKGROUND
Whether LDL or mox-LDL has a mitogenic effect on VSMC has been controversial. It is possible that LDL may not be mitogenic to VSMC but modification of LDL may confer mitogenic properties on LDL. A known mitogen for VSMC is 5HT that is released by aggregating platelets at sites of atherosclerotic changes or endothelial dysfunction. It is possible that LDL may interact with 5HT to enhance VSMC proliferation induced by 5HT.
METHODS
Growth arrested primary VSMCs were incubated with different concentrations of LDL or mox-LDL for 24 h followed by incubation with 5HT for another 24 h (mild oxidation of LDL was achieved by incubating LDL with Cu++ which increased the thiobarbituric acid product formation without a change in electrophoretic mobility). The increase in cell number or the amount of 3H-thymidine incorporated into the DNA was then measured.
RESULTS
Low density lipoprotein and mox-LDL induced significant VSMC proliferation by themselves and this effect was potentiated by 5HT. The 5HT2 receptor antagonist (LY281067) and pertussis toxin reversed only the proliferative effect of 5HT. Polyinosinic acid (poly-I), an inhibitor of scavenger receptors, did not inhibit the proliferative effect of LDL or mox-LDL or their synergistic interaction with 5HT.
CONCLUSIONS
These results suggest that LDL and mox-LDL act synergistically with 5HT in inducing VSMC proliferation. The synergistic interaction could be blocked by LY281067 and pertussis toxin but not by poly-I acid.
|
Abbreviations and Acronyms
| | BSA | = bovine serum albumin | | DMEM | = Dulbeccos modified Eagles medium | | EDTA | = ethylenediamine tetraacetic acid | | FBS | = fetal bovine serum | | HBSS | = Hanks balanced salt solution | | JNK/SAPK | = c-Jun N-terminal kinases/stress activated kinase | | LDL | = low density lipoprotein | | Lyso-PC | = lysophosphatydilcholine | | MAP-kinase | = mitogen activated protein kinase | | mox-LDL | = mildly oxidized low density lipoprotein | | PBS | = phosphate buffered saline | | poly-I | = polyinosinic acid | | PTX | = pertussis toxin | | SMC | = smooth muscle cell | | TBARS | = thiobarbituric acid reactive products | | VSMC | = vascular smooth muscle cell | | 5HT | = serotonin |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. E. Zettler, M. A. Prociuk, J. A. Austria, G. Zhong, and G. N. Pierce
Oxidized Low-Density Lipoprotein Retards the Growth of Proliferating Cells by Inhibiting Nuclear Translocation of Cell Cycle Proteins
Arterioscler Thromb Vasc Biol,
April 1, 2004;
24(4):
727 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Zettler, M. A. Prociuk, J. A. Austria, H. Massaeli, G. Zhong, and G. N. Pierce
OxLDL stimulates cell proliferation through a general induction of cell cycle proteins
Am J Physiol Heart Circ Physiol,
February 1, 2003;
284(2):
H644 - H653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. GOUNI-BERTHOLD and A. SACHINIDIS
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?
FASEB J,
October 1, 2002;
16(12):
1477 - 1487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. V. Anderson, J. McNatt, F. J. Clubb, M. Herman, J.-P. Maffrand, F. DeClerck, C. Ahn, L. M. Buja, and J. T. Willerson
Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries
Circulation,
November 6, 2001;
104(19):
2331 - 2337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Watanabe, R. Pakala, S. Koba, T. Katagiri, and C. R. Benedict
Lysophosphatidylcholine and Reactive Oxygen Species Mediate the Synergistic Effect of Mildly Oxidized LDL With Serotonin on Vascular Smooth Muscle Cell Proliferation
Circulation,
March 13, 2001;
103(10):
1440 - 1445.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|